|1.||Silva-Dias, A: 1 article (01/2013)|
|2.||Cobrado, L: 1 article (01/2013)|
|3.||Pina-Vaz, C: 1 article (01/2013)|
|4.||Rodrigues, A G: 1 article (01/2013)|
|5.||Azevedo, M M: 1 article (01/2013)|
|6.||Nuñez, María J: 1 article (01/2012)|
|7.||Cascante, Marta: 1 article (01/2012)|
|8.||Sánchez-Tena, Susana: 1 article (01/2012)|
|9.||Costoya, Noelia: 1 article (01/2012)|
|10.||Fernández-Cachón, María L: 1 article (01/2012)|
01/01/2002 - "The tumour necrosis factor-alpha (TNF) inhibitory activity of hamamelitannin from Hamamelis virginiana was investigated by assessing the TNF-mediated EAhy926 endothelial cell death and adhesiveness to monocytes. "
01/01/2002 - "Hamamelitannin from Hamamelis virginiana inhibits the tumour necrosis factor-alpha (TNF)-induced endothelial cell death in vitro."
01/27/2012 - "Treatment with these compounds reduced tumor viability and induced apoptosis, necrosis, and S-phase arrest in the cell cycle of HT29 cells, with hamamelitannin being the most efficient. "
05/01/2008 - "In a rat graft model, hamamelitannin prevented device-associated infections in vivo, including infections caused by methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis strains. "
01/01/2013 - "In vivo antibiofilm effect of cerium, chitosan and hamamelitannin against usual agents of catheter-related bloodstream infections."
01/01/2013 - "The antibiofilm effect of cerium nitrate, chitosan and hamamelitannin was tested against Staphylococcus epidermidis, Staphylococcus aureus, Acinetobacter baumannii and Candida albicans in a mouse foreign body infection model, using polyurethane catheter segments. "
|3.||Lewis Lung Carcinoma